These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 4767491)

  • 1. [Effect of various factors on in vitro output velocity from delayed-action tablets 1. Tetracycline delayed-action tablets].
    Tomassini L; Naplatanova D
    Pharmazie; 1973 Jul; 28(7):447-9. PubMed ID: 4767491
    [No Abstract]   [Full Text] [Related]  

  • 2. [Development of an oral nitroglycerin proxyphyllin retard compound].
    Ritschel WA; Clotten R
    Arzneimittelforschung; 1970 Sep; 20(9):1180-7. PubMed ID: 4992053
    [No Abstract]   [Full Text] [Related]  

  • 3. [Development of an oral retard preparation of verapamil and absorption study in the anesthetized dog].
    Mayer D; Raschack M; Kesselring K
    Arzneimittelforschung; 1975 Aug; 25(8):1272-5. PubMed ID: 241362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Differentiation of the degree of bioavailability of peroral drug forms of tetracycline hydrochloride in experiments on laboratory animals].
    Zak AF; Ermolova OB
    Antibiotiki; 1976 Feb; 21(2):151-5. PubMed ID: 1275466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug formulation and biologic availability.
    Poole JW
    Semin Drug Treat; 1971 Sep; 1(2):148-76. PubMed ID: 5153883
    [No Abstract]   [Full Text] [Related]  

  • 6. Tableting research and technology.
    Cooper J; Rees JE
    J Pharm Sci; 1972 Oct; 61(10):1511-55. PubMed ID: 4561201
    [No Abstract]   [Full Text] [Related]  

  • 7. [On the manufacture and testing of butaperazine matrix tablets with silicone varnish NH 30 as a structural substance (author's transl)].
    Kala H; Wendorff D; Moldenhauer H
    Pharmazie; 1980; 35(7):418-23. PubMed ID: 6106210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effects of some factors on the rate of the in vitro release of active substances from depot tablets. 3. The release rate of tetracycline hydrochloride from layered and nonlayered depot tablets].
    Michailova D; Naplatanova D; Slavtschev P; Tomassini L
    Pharmazie; 1978 Apr; 33(4):212-6. PubMed ID: 674317
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
    Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
    Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tablets. XVII. Effect of pressure on the liberation in vitro of sodium salicylate from prolonged-action tablets].
    Terrier JL; Cruaud-Mangenot O; Duchène D; Puisieux F
    Pharm Acta Helv; 1976; 51(5):144-52. PubMed ID: 967910
    [No Abstract]   [Full Text] [Related]  

  • 11. Strength of the insoluble residues of plastic matrix slow release tablets (Duretter) in vitro and in vivo.
    Dahlinder LE; Graffner C; Sjögren J
    Acta Pharm Suec; 1973 Sep; 10(4):323-32. PubMed ID: 4759357
    [No Abstract]   [Full Text] [Related]  

  • 12. High-amylose carboxymethyl starch matrices for oral sustained drug-release: in vitro and in vivo evaluation.
    Nabais T; Brouillet F; Kyriacos S; Mroueh M; Amores da Silva P; Bataille B; Chebli C; Cartilier L
    Eur J Pharm Biopharm; 2007 Mar; 65(3):371-8. PubMed ID: 17275270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of certain tablet formulation factors on the antimicrobial activity of tetracycline hydrochloride and chloramphenicol. 2. Effect of disintegrants.
    Asker A; el-Nakeeb M; Motawi M; el-Gindy N
    Pharmazie; 1973 Jul; 28(7):474-6. PubMed ID: 4767500
    [No Abstract]   [Full Text] [Related]  

  • 14. [Manufacturing delayed action tablet using sugar cane wax].
    Orbán E; Isaura LV
    Acta Pharm Hung; 1973 Jan; 43(1):9-13. PubMed ID: 4687825
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of microencapsulation with ethyl cellulose upon the disintegration in vivo and the dissolution of iron tablets.
    Dahlström H; Eriksson S
    Acta Pharm Suec; 1971 Nov; 8(5):505-8. PubMed ID: 5159520
    [No Abstract]   [Full Text] [Related]  

  • 16. [Compounding of pure tablets of isoniazid with prolonged action].
    Seleznev EF; Korobkov ES; Griniuk IL
    Farmatsiia; 1978; 27(4):24-6. PubMed ID: 357190
    [No Abstract]   [Full Text] [Related]  

  • 17. [Study on dissolution in vitro of Zhike Pingchuan sustained-release tablets].
    Li X; Feng Z; Huo W; Li Y; Wang B; Zhu S
    Zhongguo Zhong Yao Za Zhi; 2009 May; 34(10):1216-9. PubMed ID: 19673379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effectivness prolongation of drugs with special consideration for peroral depot drug forms].
    Hänselmann B; Voigt R
    Pharmazie; 1971 Feb; 26(2):57-77. PubMed ID: 4930108
    [No Abstract]   [Full Text] [Related]  

  • 19. New co-polymer zwitterionic matrices for sustained release of verapamil hydrochloride.
    Kostova B; Rachev D
    Acta Pharm; 2007 Dec; 57(4):429-39. PubMed ID: 18165187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the accuracy of different types of dissolution rate methods.
    Bolhuis GK; Lerk CF; Zuurman K
    Pharm Weekbl; 1973 Jan; 108(3):49-53. PubMed ID: 4699088
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.